Addex Therapeutics Ltd Stock Prediction and Forecast [ADXN]

AI-generated source summary

This analysis focuses on Addex Therapeutics (ADXN). On September 11, 2025, the system ranked ADXN as a buy candidate with a score of 2.26. Since September 9th, there's been a 4.65% gain, averaging 1.55% daily. The analysis notes ADXN broke through a declining short-term trend, suggesting a potential trend shift. Support is expected at $8.75, potentially leading to an upward movement. According to fan theory, the next peak could be $10.55, a resistance level. The three-month trend anticipates a 9.9% decline, with a possible return range of -28.67% to -10.20%. The 12-month analysis projects a -12.63% change, placing the future price between $5.15 and $8.61. On September 11, 2025, the stock increased by 5.15%, closing at $8.78, following significant price fluctuation of 12.56% between high and low ($7.80 and $8.78). Over the prior 2 weeks, there's an 11.14% gain. There are positive indicators including a Moving Average Convergence Divergence buy signal, a buy signal generated 14 days ago from a pivot bottom, as trading volume increased. Weekly volatility is high, though, at 7.10% and it is a medium risk stock. Fibonacci analysis shows the 1st resistance for the stock is $9.43 .The price to earnings ratio is 0.656. The stop-loss should be at $8.47, according to this analysis.

AI-generated summary based on the source content.

Evidence and evaluation progress

1. Original source published

   12 Sept 2025, 04:04 UTC

   The analyst published the original source item.

2. First prediction resolved

   12 Sept 2025, 13:30 UTC

   The first evaluable outcome in this case reached a terminal result.

3. Case evaluation completed

   12 Sept 2025, 13:30 UTC

   All evaluable predictions in this case reached terminal outcomes.

4. Source recorded by Tahlil Plus

   18 May 2026, 20:23 UTC

   The public source was preserved as the evidence record for this case.

5. Market predictions extracted

   18 May 2026, 20:47 UTC

   1 eligible signal linked to this case.

6. Outcome tracking started

   02 Jul 2026, 01:22 UTC

   Tahlil Plus began monitoring the extracted predictions.